CANCERCH STANDARD
The foundation of your cancer screening journey
The CANCERCH STANDARD package is the standard option within the suite of 3 in-depth cancer screening packages. With just a single blood draw, it helps detect the early risk of 14 cancers and other abnormalities thanks to advanced cfDNA analysis technology combined with artificial intelligence (AI).
CANCERCH STANDARD
| No. | Service | Purpose | Male | Female |
|---|---|---|---|---|
| Laboratory tests | ||||
| 1 | Complete peripheral blood cell analysis, 28 parameters (laser counter) | Blood diseases and blood cancers | ||
| 2 | Complete urinalysis (11 parameters) | Kidney-urinary tract diseases, metabolic disorders | ||
| 3 | Glucose quantification [Blood] | Diabetes | ||
| 4 | HbA1c quantification [Blood] | Diabetes | ||
| 5 | Urea/BUN quantification [Blood] | Kidney diseases, renal function | ||
| 6 | Creatinine quantification [Blood] | Kidney diseases, renal function | ||
| 7 | AST (GOT) activity measurement [Blood] | Liver diseases, liver function | ||
| 8 | ALT (GPT) activity measurement [Blood] | Liver diseases, liver function | ||
| 9 | GGT (Gamma Glutamyl Transferase) activity measurement [Blood] | Liver diseases, liver toxicity | ||
| 10 | Total cholesterol quantification [Blood] | Blood lipid metabolism disorders | ||
| 11 | Triglyceride quantification [Blood] | Blood lipid metabolism disorders | ||
| 12 | HDL-C (High-density lipoprotein cholesterol) quantification [Blood] | Blood lipid metabolism disorders | ||
| 13 | LDL-C (Low-density lipoprotein cholesterol) quantification [Blood] | Blood lipid metabolism disorders | ||
| 14 | Uric acid quantification [Blood] | Gout | ||
| 15 | HBsAg automated immunoassay | Hepatitis B | ||
| 16 | TSH (Thyroid Stimulating Hormone) quantification [Blood] | Thyroid diseases | ||
| 17 | FT4 (Free Thyroxine) quantification [Blood] | Thyroid diseases | ||
| 18 | Total PSA (Prostate-Specific Antigen) quantification [Blood] | Prostate cancer | — | |
| 19 | Free PSA (Prostate-Specific Antigen) quantification [Blood] | Prostate cancer | — | |
| 20 | Bacterial smear microscopy (vaginal discharge) | Vaginal infections | — | |
| 21 | Papanicolaou cytology smear (Pap smear) | Cervical cancer | — | |
| Specialist examination | ||||
| 1 | General internal medicine examination, consultation and health conclusion | Internal medicine conditions | ||
| 2 | ENT examination by endoscopy system (with image printout) | ENT diseases, nasopharyngeal cancer, etc. | ||
| 3 | Gynecological examination | Gynecological conditions | — | |
| Imaging & functional diagnostics | ||||
| 1 | Standard electrocardiogram (ECG) | Cardiovascular diseases | ||
| 2 | Abdominal ultrasound (liver & biliary, pancreas, spleen, kidneys, bladder) | Diseases of the liver, biliary tract, pancreas, spleen, kidneys, bladder, etc. | ||
| 3 | Doppler ultrasound of neck tumors, glands and lymph nodes | Neck conditions (thyroid, salivary glands, etc.) | ||
| 4 | Bilateral breast ultrasound | Breast conditions | — | |
| 5 | Bilateral breast mammography (using Lunit AI software) | Breast cancer | — | |
| 6 | Low-dose lung CT for tumor screening, coronary calcium assessment and screening for emphysema common in COPD (using AI-powered Core-line software) | Detects many abnormalities using up to 90% less X-ray radiation than conventional chest CT, helping to screen for lung cancer, lung tumors and metastatic cancer, etc. Assesses the degree of coronary artery wall calcification, screens for coronary artery disease risk and for emphysema (common in COPD). | ||
| 7 | Routine abdomen-pelvis CT (without contrast) | 1. Assessment of morphology and structure: Liver, spleen, pancreas, kidneys, adrenal glands - detection of large lesions, large tumors, clear malformations. Bladder, prostate. Small intestine, colon - obstruction, dilation, abnormal gas. 2. Detection of abnormalities: Kidney stones, ureteral stones, bladder stones. Intrahepatic bile duct stones (some cases). Calcification in soft tissue, tumors, blood vessels. Large hemorrhage. 3. Assessment of fat tissue and peri-organ spaces: Perirenal and peri-intestinal fat - detection of severe inflammation, edema, fat infiltration. Large ascites. Large tumor/inflammatory mass compressing structures. 4. Assessment of the spine and pelvic bones: Fractures, degeneration, bone tumors, destructive lesions. | ||
| 8 | Cardiovascular biological age analysis | Assesses the biological age of the heart | ||
| 9 | Body fat measurement (InBody) | Assesses body metrics | ||
| 10 | Radiation dose management system | Assesses radiation dose | ||
| Package price | ||||
| Package price (VND) | 9.000.000 đ | 10.000.000 đ | ||
| 30% discount | 6.300.000 đ | 7.000.000 đ | ||
Why CANCERCH STANDARD is a trustworthy choice
Early detection of
multiple cancers (MCED)
Cancerch uses an AI blood test to detect the risk of 6 major cancers: lung, colorectal, liver, pancreatic – biliary, esophageal and ovarian
AI-powered cfDNA analysis
Based on an AI model trained on ~5,000 cancer patients and healthy individuals, the system identifies characteristic DNA patterns to predict the likelihood of cancer
High accuracy
Cancerch achieves 99% specificity, minimizing the risk of false positives, while also offering good sensitivity across many cancers (such as liver 82.4%, pancreatic – biliary 76.1%)
Personalized risk comparison
Results show each individual’s cancer risk compared with the population of the same age and gender, making it easy to understand and monitor your health
Regular monitoring
and personalized guidance
Cancerch uses an AI blood test to detect the risk of 6 major cancers: lung, colorectal, liver, pancreatic – biliary, esophageal and ovarian
Versatile and clinically supportive
Cancerch uses an AI blood test to detect the risk of 6 major cancers: lung, colorectal, liver, pancreatic – biliary, esophageal and ovarian